Cervical cancer kills an estimated 570,000 women globally each year, with sub-Saharan Africa bearing a disproportionate share of that burden yet HPV vaccine programmes launched with donor fanfare are stalling at under 50% coverage in several countries across the region [1]. The gap between announcement and delivery is not a footnote; it is a death sentence deferred.

Workforce bottlenecks sit at the heart of the delivery failure. Uganda and peer nations have joined a continental push that treats trained health workers, not facilities or drugs as the irreducible unit of system resilience, but vaccine rollouts are outpacing the cadre of nurses and community health workers needed to administer them at scale [1]. You cannot immunise a girl you cannot reach.

Donor driven programme design compounds the problem. Fanfare heavy launch events mask fragile supply chains and weak cold storage infrastructure in rural districts, where the girls most at risk of cervical cancer are least likely to encounter a functioning immunisation point [1]. Coverage figures reported at the national level routinely obscure catastrophic sub national gaps.